Representation and outcomes of individuals with major depression in routine care who are ineligible for randomized controlled trials: a nationwide register‐based study
Repräsentation und Outcomes von Personen mit Major Depression in der Routineversorgung, die für randomisierte kontrollierte Studien nicht infrage kommen: eine landesweite registerbasierte Studie
World Psychiatry · 2026-02 · 25 (1) · 117-124
DOI: 10.1002/wps.70013 ↗Auf einen Blick
Mehr als ein Drittel der Patient:innen mit MDD in der Routineversorgung war für RCTs nicht geeignet. Diese Gruppe hatte in Finnland und Schweden ein höheres Risiko für den primären kombinierten Endpunkt.
Fragestellung
Wie groß ist der Anteil RCT-ungeeigneter Personen mit MDD unter Erhaltungstherapie und wie unterscheiden sich ihre Outcomes von RCT-geeigneten Personen?
Methode
Registerbasierte Kohortenstudie in Finnland (2004–2018) und Schweden (2006–2021); Klassifikation nach standardisierten RCT-Kriterien; Cox-Modelle für 6 Monate Follow-up.
Ergebnisse
73.720 Personen in Finnland und 135.092 in Schweden. 33,5 % bzw. 35,3 % waren RCT-ungeeignet. HR für den primären Endpunkt: 2,44 (95 %-KI 2,15–2,76) bzw. 2,61 (95 %-KI 2,37–2,87).
Schlussfolgerung der Autor:innen
Die Autor:innen folgern, dass inklusivere Einschlusskriterien für RCTs und ihre Verknüpfung mit Real-World-Daten nötig sind, um die Generalisierbarkeit von Evidenz und Leitlinien zu verbessern.
Kernaussagen
- 33,5 % in Finnland und 35,3 % in Schweden waren RCT-ungeeignet
- HR für den primären Endpunkt: 2,44 und 2,61
- Etwa ein Drittel des Risikos war auf Ineligibilität zurückzuführen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift World Psychiatry, online erschienen am 14.01.2026. Verfasst von Aleksi Hamina und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Depression
Abstract (Originalsprache)
Randomized controlled trials (RCTs) are the foundation of current clinical treatment guidelines. However, they may not reflect real‐world populations, due to strict eligibility criteria. We determined the proportion of individuals with major depressive disorder (MDD) receiving maintenance antidepressant treatment in routine care who would be ineligible for RCTs, and compared their outcomes with those who were eligible. Utilizing specialized health care registers in Finland (2004‐2018) and Sweden (2006‐2021), we identified adults diagnosed with non‐psychotic MDD (ICD‐10: F32, F33) who were stabilized on maintenance antidepressant monotherapy. Through multidisciplinary expert consensus on latest meta‐analytic evidence, we derived a standardized list of RCT inclusion and exclusion criteria. These criteria were systematically applied to classify individuals as RCT‐eligible or RCT‐ineligible. We then used Cox proportional models to derive hazard ratios (HRs) of a composite primary outcome of hospitalization due to any psychiatric reason or suicide attempt, and all‐cause mortality, during a 6‐month follow‐up. Secondary outcomes were treatment changes (i.e., discontinuation, switch or augmentation) and psychiatric sick leave ≥2 weeks. A total of 73,720 individuals in Finland and 135,092 in Sweden were included. More than one third of patients with MDD (33.5% in Finland and 35.3% in Sweden) were found to be ineligible for RCTs. The most common reasons for ineligibility were comorbidities (serious somatic disease, other psychiatric disorders, or substance use disorder). RCT‐ineligible individuals had more than twice the risk of the composite primary outcome compared to eligible individuals (HR=2.44, 95% CI: 2.15‐2.76 in Finland; HR=2.61, 95% CI: 2.37‐2.87 in Sweden). Approximately one third of the composite primary outcome was attributable to RCT‐ineligibility factors (32.5%, 95% CI: 27.9‐37.1 for Finland; 36.2%, 95% CI: 32.6‐39.8 for Sweden). Risk of treatment change was slightly but significantly higher in ineligible individuals. Findings were consistent in a wide range of sensitivity analyses. We conclude that more inclusive eligibility criteria for RCTs, and their integration with real‐world data, are needed to improve the generalizability of antidepressant trial evidence and MDD clinical treatment guidelines.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.
- Norwegian Centre for Addiction Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- Department of Psychiatry, Amsterdam University Medical Center, Amsterdam, The Netherlands.
- Department of Clinical Psychiatry, School of Medicine, University of Panama, Panama City, Panama.
- Center of Population Sciences for Health Empowerment, Florida State University, Tallahassee, FL, USA.
- Instituto de Investigaciones Científicas y Servicios de Alta Tecnología, Panama City, Panama.
Zitieren
APA
Hamina, A., Pinzón-Espinosa, J., Taipale, H., Schneider-Thoma, J., Radua, J., Efthimiou, O., Cardoner, N., Correll, C. U., Fusar-Poli, P., Mittendorfer-Rutz, E., Penninx, B. W. J. H., Ruhe, H. G., Tanskanen, A., Vinkers, C. H., Leucht, S., Vieta, E., Cipriani, A., Tiihonen, J., & Luykx, J. J. (2026). Representation and outcomes of individuals with major depression in routine care who are ineligible for randomized controlled trials: a nationwide register‐based study. World Psychiatry, 25(1), 117-124. https://doi.org/10.1002/wps.70013
Vancouver
Hamina A, Pinzón-Espinosa J, Taipale H, Schneider-Thoma J, Radua J, Efthimiou O, et al. Representation and outcomes of individuals with major depression in routine care who are ineligible for randomized controlled trials: a nationwide register‐based study. World Psychiatry. 2026;25(1):117-124. doi:10.1002/wps.70013
BibTeX
@article{Hamina2026,
author = {Hamina, Aleksi and Pinzón-Espinosa, Justo and Taipale, Heidi and Schneider-Thoma, Johannes and Radua, Joaquim and Efthimiou, Orestis and Cardoner, Narcís and Correll, Christoph U and Fusar-Poli, Paolo and Mittendorfer-Rutz, Ellenor and Penninx, Brenda W J H and Ruhe, Henricus G and Tanskanen, Antti and Vinkers, Christiaan H and Leucht, Stefan and Vieta, Eduard and Cipriani, Andrea and Tiihonen, Jari and Luykx, Jurjen J},
title = {Representation and outcomes of individuals with major depression in routine care who are ineligible for randomized controlled trials: a nationwide register‐based study},
journal = {World Psychiatry},
year = {2026},
volume = {25},
number = {1},
pages = {117--124},
doi = {10.1002/wps.70013}
}
EUVIMED